nodes	percent_of_prediction	percent_of_DWPC	metapath
Regadenoson—ADORA2A—Dyphylline—asthma	0.288	0.405	CbGbCtD
Regadenoson—ADORA2A—Aminophylline—asthma	0.218	0.307	CbGbCtD
Regadenoson—ADORA2A—Theophylline—asthma	0.205	0.288	CbGbCtD
Regadenoson—Azacitidine—DNMT1—asthma	0.00159	0.588	CrCbGaD
Regadenoson—Adenosine monophosphate—PDE4D—asthma	0.000627	0.231	CrCbGaD
Regadenoson—Adenosine monophosphate—PDE4B—asthma	0.00049	0.181	CrCbGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—ITPR1—asthma	0.000198	0.00302	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—EDNRB—asthma	0.000197	0.003	CbGpPWpGaD
Regadenoson—ADORA2A—G alpha (s) signalling events—POMC—asthma	0.000196	0.00299	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CCR4—asthma	0.000196	0.00298	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—NPS—asthma	0.000195	0.00297	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—asthma	0.000195	0.00297	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—C3AR1—asthma	0.000193	0.00293	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—asthma	0.000191	0.00291	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—CD86—asthma	0.000189	0.00287	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CYSLTR2—asthma	0.000185	0.00282	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—AGTR1—asthma	0.000184	0.00281	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—C5—asthma	0.000182	0.00277	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—TACR1—asthma	0.000182	0.00277	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—ADCY2—asthma	0.000182	0.00277	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—LTB4R—asthma	0.000179	0.00273	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—PTGDR—asthma	0.000179	0.00273	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—ADRB2—asthma	0.000175	0.00266	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—C3AR1—asthma	0.000175	0.00266	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—BDKRB2—asthma	0.000175	0.00266	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—PPP2CA—asthma	0.00017	0.0026	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CYSLTR2—asthma	0.000168	0.00256	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CCR3—asthma	0.000166	0.00253	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—NTRK1—asthma	0.000163	0.00248	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CCL22—asthma	0.000163	0.00248	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—PTGDR—asthma	0.000163	0.00248	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—LTB4R—asthma	0.000163	0.00248	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—NPY—asthma	0.000162	0.00247	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—PDGFB—asthma	0.000159	0.00242	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—KNG1—asthma	0.000159	0.00242	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—asthma	0.000158	0.00241	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—AGTR2—asthma	0.000156	0.00238	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—LEP—asthma	0.000155	0.00236	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—asthma	0.000154	0.00235	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—ITPR1—asthma	0.000152	0.00232	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—HRH4—asthma	0.000152	0.00232	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—PMCH—asthma	0.000152	0.00232	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—PTGDR2—asthma	0.000152	0.00232	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—NPSR1—asthma	0.000152	0.00232	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—asthma	0.00015	0.00228	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—EDNRB—asthma	0.00015	0.00228	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CSF2RB—asthma	0.000149	0.00227	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—NPS—asthma	0.000148	0.00226	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—TAC1—asthma	0.000148	0.00226	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CCR8—asthma	0.000146	0.00222	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—TACR2—asthma	0.000146	0.00222	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CXCR3—asthma	0.000145	0.00222	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—CD86—asthma	0.000145	0.00221	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—NOS2—asthma	0.000145	0.0022	CbGpPWpGaD
Regadenoson—ADORA2A—GPCRs, Class A Rhodopsin-like—CCR5—asthma	0.00014	0.00213	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—HRH4—asthma	0.000138	0.00211	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—PMCH—asthma	0.000138	0.00211	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—NPSR1—asthma	0.000138	0.00211	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—PTGDR2—asthma	0.000138	0.00211	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CSF2RB—asthma	0.000135	0.00206	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—EDN1—asthma	0.000134	0.00204	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—BDKRB2—asthma	0.000133	0.00203	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL5—asthma	0.000133	0.00202	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CCR8—asthma	0.000133	0.00202	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—TACR2—asthma	0.000133	0.00202	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—PPP2CA—asthma	0.000131	0.002	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CCL17—asthma	0.00013	0.00198	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6R—asthma	0.000128	0.00194	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—PDE4A—asthma	0.000128	0.00194	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—PDGFB—asthma	0.000122	0.00186	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—SERPINE1—asthma	0.000122	0.00186	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—KNG1—asthma	0.000121	0.00184	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—AGTR1—asthma	0.00012	0.00183	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—asthma	0.00012	0.00182	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CYSLTR1—asthma	0.000119	0.00182	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CXCL10—asthma	0.000118	0.00179	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—C3—asthma	0.000117	0.00178	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—PDE4A—asthma	0.000116	0.00176	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—UTS2—asthma	0.000115	0.00176	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—C5AR1—asthma	0.000115	0.00176	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—VIP—asthma	0.000115	0.00176	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—RHOA—asthma	0.000115	0.00176	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—ADRB2—asthma	0.000114	0.00174	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CCR4—asthma	0.000111	0.00168	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CYSLTR1—asthma	0.000108	0.00165	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—IL2RB—asthma	0.000106	0.00162	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—PDE4D—asthma	0.000106	0.00161	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—VIP—asthma	0.000105	0.0016	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—C5AR1—asthma	0.000105	0.0016	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—UTS2—asthma	0.000105	0.0016	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CCL11—asthma	0.000105	0.0016	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—FCER2—asthma	0.000103	0.00157	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—C3AR1—asthma	0.000103	0.00157	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—C5—asthma	0.000103	0.00157	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—PDE4B—asthma	0.000103	0.00157	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—TACR1—asthma	0.000103	0.00157	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—EDN1—asthma	0.000102	0.00155	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CCL5—asthma	0.000101	0.00154	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CCR4—asthma	0.0001	0.00153	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CYSLTR2—asthma	9.95e-05	0.00151	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—IL6R—asthma	9.81e-05	0.00149	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—IL2RB—asthma	9.67e-05	0.00147	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—LTB4R—asthma	9.61e-05	0.00146	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PTGDR—asthma	9.61e-05	0.00146	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCL22—asthma	9.61e-05	0.00146	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—PDE4D—asthma	9.58e-05	0.00146	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CCR3—asthma	9.41e-05	0.00143	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—POMC—asthma	9.36e-05	0.00143	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—PDE4B—asthma	9.34e-05	0.00142	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—C5—asthma	9.34e-05	0.00142	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—TACR1—asthma	9.34e-05	0.00142	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—PTEN—asthma	9.28e-05	0.00141	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—NPY—asthma	9.17e-05	0.0014	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—asthma	9.16e-05	0.00139	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CCR5—asthma	9.12e-05	0.00139	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—PTEN—asthma	9.1e-05	0.00139	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—C3—asthma	8.91e-05	0.00136	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—RHOA—asthma	8.86e-05	0.00135	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—AGTR2—asthma	8.84e-05	0.00135	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CCR3—asthma	8.54e-05	0.0013	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—EDNRB—asthma	8.47e-05	0.00129	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—TAC1—asthma	8.38e-05	0.00128	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—NPS—asthma	8.38e-05	0.00128	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—NPY—asthma	8.32e-05	0.00127	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CXCR3—asthma	8.22e-05	0.00125	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PTGDR2—asthma	8.17e-05	0.00124	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NPSR1—asthma	8.17e-05	0.00124	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—HRH4—asthma	8.17e-05	0.00124	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PMCH—asthma	8.17e-05	0.00124	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—STAT3—asthma	8.14e-05	0.00124	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—AGTR2—asthma	8.03e-05	0.00122	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CSF2RB—asthma	7.99e-05	0.00122	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—TACR2—asthma	7.83e-05	0.00119	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCR8—asthma	7.83e-05	0.00119	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—IL5—asthma	7.79e-05	0.00119	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—EDNRB—asthma	7.69e-05	0.00117	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCL17—asthma	7.68e-05	0.00117	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—TAC1—asthma	7.61e-05	0.00116	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—NPS—asthma	7.61e-05	0.00116	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—BDKRB2—asthma	7.52e-05	0.00115	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CXCR3—asthma	7.47e-05	0.00114	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—asthma	7.4e-05	0.00113	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—ADCY2—asthma	7.28e-05	0.00111	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—IL3—asthma	7.25e-05	0.0011	CbGpPWpGaD
Regadenoson—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—asthma	7.24e-05	0.0011	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—POMC—asthma	7.13e-05	0.00109	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—IL5—asthma	7.08e-05	0.00108	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—PTEN—asthma	7e-05	0.00107	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CCL2—asthma	6.97e-05	0.00106	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PDE4A—asthma	6.84e-05	0.00104	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—KIF3A—asthma	6.84e-05	0.00104	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—KNG1—asthma	6.84e-05	0.00104	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—BDKRB2—asthma	6.83e-05	0.00104	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—AGTR1—asthma	6.8e-05	0.00104	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CXCL10—asthma	6.65e-05	0.00101	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—ADCY2—asthma	6.61e-05	0.00101	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—IL3—asthma	6.58e-05	0.001	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—ADRB2—asthma	6.45e-05	0.000983	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CYSLTR1—asthma	6.41e-05	0.000976	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by NGF—STAT3—asthma	6.26e-05	0.000953	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—KNG1—asthma	6.21e-05	0.000946	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCL11—asthma	6.19e-05	0.000943	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—UTS2—asthma	6.19e-05	0.000943	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CMA1—asthma	6.19e-05	0.000943	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—VIP—asthma	6.19e-05	0.000943	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—C5AR1—asthma	6.19e-05	0.000943	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—AGTR1—asthma	6.18e-05	0.00094	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—ITPR1—asthma	6.1e-05	0.000929	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—CXCL10—asthma	6.03e-05	0.000919	CbGpPWpGaD
Regadenoson—Ill-defined disorder—Hydrocortisone—asthma	5.96e-05	0.00027	CcSEcCtD
Regadenoson—Vomiting—Salbutamol—asthma	5.95e-05	0.00027	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—CCR4—asthma	5.93e-05	0.000904	CbGpPWpGaD
Regadenoson—Malaise—Prednisolone—asthma	5.93e-05	0.000269	CcSEcCtD
Regadenoson—Dysgeusia—Triamcinolone—asthma	5.92e-05	0.000268	CcSEcCtD
Regadenoson—Rash—Salbutamol—asthma	5.9e-05	0.000267	CcSEcCtD
Regadenoson—Syncope—Prednisolone—asthma	5.89e-05	0.000267	CcSEcCtD
Regadenoson—Dermatitis—Salbutamol—asthma	5.89e-05	0.000267	CcSEcCtD
Regadenoson—Eye disorder—Betamethasone—asthma	5.89e-05	0.000267	CcSEcCtD
Regadenoson—Eye disorder—Dexamethasone—asthma	5.89e-05	0.000267	CcSEcCtD
Regadenoson—Nausea—Arformoterol—asthma	5.88e-05	0.000267	CcSEcCtD
Regadenoson—Nausea—Formoterol—asthma	5.88e-05	0.000267	CcSEcCtD
Regadenoson—Angioedema—Hydrocortisone—asthma	5.86e-05	0.000266	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—ADRB2—asthma	5.86e-05	0.000892	CbGpPWpGaD
Regadenoson—Headache—Salbutamol—asthma	5.86e-05	0.000266	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—STAT6—asthma	5.82e-05	0.000886	CbGpPWpGaD
Regadenoson—ADORA2A—Circadian rythm related genes—IL6—asthma	5.8e-05	0.000883	CbGpPWpGaD
Regadenoson—Malaise—Hydrocortisone—asthma	5.79e-05	0.000262	CcSEcCtD
Regadenoson—Loss of consciousness—Prednisolone—asthma	5.78e-05	0.000262	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—EDN1—asthma	5.77e-05	0.000878	CbGpPWpGaD
Regadenoson—Nausea—Montelukast—asthma	5.76e-05	0.000261	CcSEcCtD
Regadenoson—Vomiting—Budesonide—asthma	5.76e-05	0.000261	CcSEcCtD
Regadenoson—Syncope—Hydrocortisone—asthma	5.76e-05	0.000261	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—CCL5—asthma	5.72e-05	0.000871	CbGpPWpGaD
Regadenoson—Angiopathy—Betamethasone—asthma	5.72e-05	0.000259	CcSEcCtD
Regadenoson—Angiopathy—Dexamethasone—asthma	5.72e-05	0.000259	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—IL2RB—asthma	5.71e-05	0.00087	CbGpPWpGaD
Regadenoson—Rash—Budesonide—asthma	5.71e-05	0.000259	CcSEcCtD
Regadenoson—Dermatitis—Budesonide—asthma	5.71e-05	0.000259	CcSEcCtD
Regadenoson—Convulsion—Prednisolone—asthma	5.69e-05	0.000258	CcSEcCtD
Regadenoson—ADORA2A—Signaling by NGF—EGFR—asthma	5.69e-05	0.000866	CbGpPWpGaD
Regadenoson—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—asthma	5.68e-05	0.000866	CbGpPWpGaD
Regadenoson—Headache—Budesonide—asthma	5.67e-05	0.000257	CcSEcCtD
Regadenoson—Hypertension—Prednisolone—asthma	5.67e-05	0.000257	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—PDE4D—asthma	5.66e-05	0.000862	CbGpPWpGaD
Regadenoson—Loss of consciousness—Hydrocortisone—asthma	5.64e-05	0.000256	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—CSF2—asthma	5.63e-05	0.000858	CbGpPWpGaD
Regadenoson—Ill-defined disorder—Triamcinolone—asthma	5.61e-05	0.000254	CcSEcCtD
Regadenoson—Ill-defined disorder—Methylprednisolone—asthma	5.6e-05	0.000254	CcSEcCtD
Regadenoson—Bradycardia—Prednisone—asthma	5.58e-05	0.000253	CcSEcCtD
Regadenoson—Convulsion—Hydrocortisone—asthma	5.56e-05	0.000252	CcSEcCtD
Regadenoson—Nausea—Salbutamol—asthma	5.55e-05	0.000252	CcSEcCtD
Regadenoson—Hypertension—Hydrocortisone—asthma	5.54e-05	0.000251	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—ITPR1—asthma	5.54e-05	0.000844	CbGpPWpGaD
Regadenoson—Discomfort—Prednisolone—asthma	5.53e-05	0.000251	CcSEcCtD
Regadenoson—Angioedema—Triamcinolone—asthma	5.52e-05	0.00025	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—C5—asthma	5.52e-05	0.00084	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PDE4B—asthma	5.52e-05	0.00084	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—TACR1—asthma	5.52e-05	0.00084	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR ligand binding—CXCL8—asthma	5.51e-05	0.00084	CbGpPWpGaD
Regadenoson—Angioedema—Methylprednisolone—asthma	5.51e-05	0.00025	CcSEcCtD
Regadenoson—Erythema—Betamethasone—asthma	5.48e-05	0.000249	CcSEcCtD
Regadenoson—Erythema—Dexamethasone—asthma	5.48e-05	0.000249	CcSEcCtD
Regadenoson—Myalgia—Hydrocortisone—asthma	5.46e-05	0.000248	CcSEcCtD
Regadenoson—Malaise—Triamcinolone—asthma	5.45e-05	0.000247	CcSEcCtD
Regadenoson—Anxiety—Hydrocortisone—asthma	5.45e-05	0.000247	CcSEcCtD
Regadenoson—Malaise—Methylprednisolone—asthma	5.44e-05	0.000247	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	5.43e-05	0.000246	CcSEcCtD
Regadenoson—Syncope—Triamcinolone—asthma	5.42e-05	0.000246	CcSEcCtD
Regadenoson—Syncope—Methylprednisolone—asthma	5.41e-05	0.000245	CcSEcCtD
Regadenoson—Discomfort—Hydrocortisone—asthma	5.4e-05	0.000245	CcSEcCtD
Regadenoson—Connective tissue disorder—Prednisone—asthma	5.39e-05	0.000244	CcSEcCtD
Regadenoson—Nausea—Budesonide—asthma	5.38e-05	0.000244	CcSEcCtD
Regadenoson—Anaphylactic shock—Prednisolone—asthma	5.36e-05	0.000243	CcSEcCtD
Regadenoson—Loss of consciousness—Triamcinolone—asthma	5.31e-05	0.000241	CcSEcCtD
Regadenoson—Loss of consciousness—Methylprednisolone—asthma	5.3e-05	0.00024	CcSEcCtD
Regadenoson—Shock—Prednisolone—asthma	5.28e-05	0.000239	CcSEcCtD
Regadenoson—Cough—Triamcinolone—asthma	5.27e-05	0.000239	CcSEcCtD
Regadenoson—Anaphylactic shock—Hydrocortisone—asthma	5.24e-05	0.000238	CcSEcCtD
Regadenoson—Convulsion—Triamcinolone—asthma	5.24e-05	0.000237	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—EDN1—asthma	5.24e-05	0.000797	CbGpPWpGaD
Regadenoson—Tachycardia—Prednisolone—asthma	5.23e-05	0.000237	CcSEcCtD
Regadenoson—Convulsion—Methylprednisolone—asthma	5.22e-05	0.000237	CcSEcCtD
Regadenoson—Hypertension—Triamcinolone—asthma	5.22e-05	0.000237	CcSEcCtD
Regadenoson—Hypertension—Methylprednisolone—asthma	5.21e-05	0.000236	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—CCL5—asthma	5.19e-05	0.000791	CbGpPWpGaD
Regadenoson—Hyperhidrosis—Prednisolone—asthma	5.19e-05	0.000235	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—PLA2G4A—asthma	5.17e-05	0.000788	CbGpPWpGaD
Regadenoson—Shock—Hydrocortisone—asthma	5.15e-05	0.000234	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—CCR5—asthma	5.15e-05	0.000785	CbGpPWpGaD
Regadenoson—Myalgia—Triamcinolone—asthma	5.15e-05	0.000233	CcSEcCtD
Regadenoson—Nervous system disorder—Hydrocortisone—asthma	5.14e-05	0.000233	CcSEcCtD
Regadenoson—Myalgia—Methylprednisolone—asthma	5.13e-05	0.000233	CcSEcCtD
Regadenoson—Arthralgia—Methylprednisolone—asthma	5.13e-05	0.000233	CcSEcCtD
Regadenoson—Eye disorder—Prednisone—asthma	5.13e-05	0.000232	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—CSF2—asthma	5.12e-05	0.000779	CbGpPWpGaD
Regadenoson—Anxiety—Methylprednisolone—asthma	5.12e-05	0.000232	CcSEcCtD
Regadenoson—Tachycardia—Hydrocortisone—asthma	5.11e-05	0.000232	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	5.1e-05	0.000231	CcSEcCtD
Regadenoson—Flushing—Prednisone—asthma	5.09e-05	0.000231	CcSEcCtD
Regadenoson—Skin disorder—Hydrocortisone—asthma	5.09e-05	0.000231	CcSEcCtD
Regadenoson—Ill-defined disorder—Dexamethasone—asthma	5.09e-05	0.000231	CcSEcCtD
Regadenoson—Ill-defined disorder—Betamethasone—asthma	5.09e-05	0.000231	CcSEcCtD
Regadenoson—Discomfort—Triamcinolone—asthma	5.08e-05	0.000231	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—IL2RA—asthma	5.08e-05	0.000774	CbGpPWpGaD
Regadenoson—Discomfort—Methylprednisolone—asthma	5.07e-05	0.00023	CcSEcCtD
Regadenoson—Hyperhidrosis—Hydrocortisone—asthma	5.06e-05	0.00023	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—CCR3—asthma	5.05e-05	0.000768	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—C3—asthma	5.04e-05	0.000767	CbGpPWpGaD
Regadenoson—Angioedema—Betamethasone—asthma	5.01e-05	0.000227	CcSEcCtD
Regadenoson—Angioedema—Dexamethasone—asthma	5.01e-05	0.000227	CcSEcCtD
Regadenoson—Angiopathy—Prednisone—asthma	4.98e-05	0.000226	CcSEcCtD
Regadenoson—Immune system disorder—Prednisone—asthma	4.96e-05	0.000225	CcSEcCtD
Regadenoson—Malaise—Betamethasone—asthma	4.95e-05	0.000224	CcSEcCtD
Regadenoson—Malaise—Dexamethasone—asthma	4.95e-05	0.000224	CcSEcCtD
Regadenoson—Anaphylactic shock—Triamcinolone—asthma	4.93e-05	0.000224	CcSEcCtD
Regadenoson—Anaphylactic shock—Methylprednisolone—asthma	4.92e-05	0.000223	CcSEcCtD
Regadenoson—Syncope—Betamethasone—asthma	4.92e-05	0.000223	CcSEcCtD
Regadenoson—Syncope—Dexamethasone—asthma	4.92e-05	0.000223	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—NPY—asthma	4.92e-05	0.000749	CbGpPWpGaD
Regadenoson—Hypotension—Hydrocortisone—asthma	4.89e-05	0.000222	CcSEcCtD
Regadenoson—Shock—Triamcinolone—asthma	4.85e-05	0.00022	CcSEcCtD
Regadenoson—Insomnia—Prednisolone—asthma	4.85e-05	0.00022	CcSEcCtD
Regadenoson—Shock—Methylprednisolone—asthma	4.84e-05	0.00022	CcSEcCtD
Regadenoson—Nervous system disorder—Methylprednisolone—asthma	4.83e-05	0.000219	CcSEcCtD
Regadenoson—Loss of consciousness—Dexamethasone—asthma	4.82e-05	0.000219	CcSEcCtD
Regadenoson—Loss of consciousness—Betamethasone—asthma	4.82e-05	0.000219	CcSEcCtD
Regadenoson—Paraesthesia—Prednisolone—asthma	4.82e-05	0.000218	CcSEcCtD
Regadenoson—Tachycardia—Triamcinolone—asthma	4.81e-05	0.000218	CcSEcCtD
Regadenoson—Mental disorder—Prednisone—asthma	4.81e-05	0.000218	CcSEcCtD
Regadenoson—Tachycardia—Methylprednisolone—asthma	4.8e-05	0.000218	CcSEcCtD
Regadenoson—Skin disorder—Methylprednisolone—asthma	4.78e-05	0.000217	CcSEcCtD
Regadenoson—Erythema—Prednisone—asthma	4.78e-05	0.000217	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Hydrocortisone—asthma	4.77e-05	0.000216	CcSEcCtD
Regadenoson—Hyperhidrosis—Triamcinolone—asthma	4.77e-05	0.000216	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—PPP2CA—asthma	4.77e-05	0.000726	CbGpPWpGaD
Regadenoson—Hyperhidrosis—Methylprednisolone—asthma	4.76e-05	0.000216	CcSEcCtD
Regadenoson—Convulsion—Dexamethasone—asthma	4.75e-05	0.000215	CcSEcCtD
Regadenoson—Convulsion—Betamethasone—asthma	4.75e-05	0.000215	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—AGTR2—asthma	4.74e-05	0.000722	CbGpPWpGaD
Regadenoson—Insomnia—Hydrocortisone—asthma	4.74e-05	0.000215	CcSEcCtD
Regadenoson—Hypertension—Dexamethasone—asthma	4.73e-05	0.000215	CcSEcCtD
Regadenoson—Hypertension—Betamethasone—asthma	4.73e-05	0.000215	CcSEcCtD
Regadenoson—Paraesthesia—Hydrocortisone—asthma	4.7e-05	0.000213	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—CCR5—asthma	4.68e-05	0.000713	CbGpPWpGaD
Regadenoson—Myalgia—Betamethasone—asthma	4.67e-05	0.000212	CcSEcCtD
Regadenoson—Myalgia—Dexamethasone—asthma	4.67e-05	0.000212	CcSEcCtD
Regadenoson—Anxiety—Dexamethasone—asthma	4.65e-05	0.000211	CcSEcCtD
Regadenoson—Anxiety—Betamethasone—asthma	4.65e-05	0.000211	CcSEcCtD
Regadenoson—Discomfort—Dexamethasone—asthma	4.61e-05	0.000209	CcSEcCtD
Regadenoson—Discomfort—Betamethasone—asthma	4.61e-05	0.000209	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—IL2RA—asthma	4.61e-05	0.000702	CbGpPWpGaD
Regadenoson—Hypotension—Methylprednisolone—asthma	4.6e-05	0.000209	CcSEcCtD
Regadenoson—Pain—Prednisolone—asthma	4.59e-05	0.000208	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—C3—asthma	4.57e-05	0.000697	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—EDNRB—asthma	4.54e-05	0.000692	CbGpPWpGaD
Regadenoson—Gastrointestinal disorder—Hydrocortisone—asthma	4.52e-05	0.000205	CcSEcCtD
Regadenoson—Vision blurred—Prednisone—asthma	4.5e-05	0.000204	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—NPS—asthma	4.5e-05	0.000685	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—TAC1—asthma	4.5e-05	0.000685	CbGpPWpGaD
Regadenoson—Musculoskeletal discomfort—Triamcinolone—asthma	4.49e-05	0.000204	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Methylprednisolone—asthma	4.48e-05	0.000203	CcSEcCtD
Regadenoson—Pain—Hydrocortisone—asthma	4.48e-05	0.000203	CcSEcCtD
Regadenoson—Anaphylactic shock—Betamethasone—asthma	4.48e-05	0.000203	CcSEcCtD
Regadenoson—Anaphylactic shock—Dexamethasone—asthma	4.48e-05	0.000203	CcSEcCtD
Regadenoson—Insomnia—Triamcinolone—asthma	4.46e-05	0.000202	CcSEcCtD
Regadenoson—Insomnia—Methylprednisolone—asthma	4.45e-05	0.000202	CcSEcCtD
Regadenoson—Ill-defined disorder—Prednisone—asthma	4.43e-05	0.000201	CcSEcCtD
Regadenoson—Paraesthesia—Triamcinolone—asthma	4.43e-05	0.000201	CcSEcCtD
Regadenoson—Feeling abnormal—Prednisolone—asthma	4.42e-05	0.0002	CcSEcCtD
Regadenoson—Paraesthesia—Methylprednisolone—asthma	4.42e-05	0.0002	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—CXCR3—asthma	4.41e-05	0.000672	CbGpPWpGaD
Regadenoson—Shock—Betamethasone—asthma	4.4e-05	0.0002	CcSEcCtD
Regadenoson—Shock—Dexamethasone—asthma	4.4e-05	0.0002	CcSEcCtD
Regadenoson—Dyspnoea—Triamcinolone—asthma	4.4e-05	0.000199	CcSEcCtD
Regadenoson—Nervous system disorder—Dexamethasone—asthma	4.39e-05	0.000199	CcSEcCtD
Regadenoson—Nervous system disorder—Betamethasone—asthma	4.39e-05	0.000199	CcSEcCtD
Regadenoson—ADORA2A—Signaling by NGF—IL6—asthma	4.37e-05	0.000666	CbGpPWpGaD
Regadenoson—Tachycardia—Dexamethasone—asthma	4.37e-05	0.000198	CcSEcCtD
Regadenoson—Tachycardia—Betamethasone—asthma	4.37e-05	0.000198	CcSEcCtD
Regadenoson—Angioedema—Prednisone—asthma	4.36e-05	0.000198	CcSEcCtD
Regadenoson—Hyperhidrosis—Dexamethasone—asthma	4.33e-05	0.000196	CcSEcCtD
Regadenoson—Hyperhidrosis—Betamethasone—asthma	4.33e-05	0.000196	CcSEcCtD
Regadenoson—Feeling abnormal—Hydrocortisone—asthma	4.32e-05	0.000196	CcSEcCtD
Regadenoson—Malaise—Prednisone—asthma	4.31e-05	0.000195	CcSEcCtD
Regadenoson—Gastrointestinal pain—Hydrocortisone—asthma	4.28e-05	0.000194	CcSEcCtD
Regadenoson—Syncope—Prednisone—asthma	4.28e-05	0.000194	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—CYBA—asthma	4.27e-05	0.000651	CbGpPWpGaD
Regadenoson—Urticaria—Prednisolone—asthma	4.26e-05	0.000193	CcSEcCtD
Regadenoson—Pain—Triamcinolone—asthma	4.22e-05	0.000191	CcSEcCtD
Regadenoson—Loss of consciousness—Prednisone—asthma	4.2e-05	0.00019	CcSEcCtD
Regadenoson—Hypotension—Betamethasone—asthma	4.18e-05	0.00019	CcSEcCtD
Regadenoson—Hypotension—Dexamethasone—asthma	4.18e-05	0.00019	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—PARP1—asthma	4.18e-05	0.000637	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IL5—asthma	4.18e-05	0.000637	CbGpPWpGaD
Regadenoson—Urticaria—Hydrocortisone—asthma	4.16e-05	0.000189	CcSEcCtD
Regadenoson—Abdominal pain—Hydrocortisone—asthma	4.14e-05	0.000188	CcSEcCtD
Regadenoson—Convulsion—Prednisone—asthma	4.14e-05	0.000188	CcSEcCtD
Regadenoson—Hypertension—Prednisone—asthma	4.12e-05	0.000187	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Dexamethasone—asthma	4.08e-05	0.000185	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Betamethasone—asthma	4.08e-05	0.000185	CcSEcCtD
Regadenoson—Myalgia—Prednisone—asthma	4.07e-05	0.000184	CcSEcCtD
Regadenoson—Arthralgia—Prednisone—asthma	4.07e-05	0.000184	CcSEcCtD
Regadenoson—Feeling abnormal—Triamcinolone—asthma	4.06e-05	0.000184	CcSEcCtD
Regadenoson—Feeling abnormal—Methylprednisolone—asthma	4.06e-05	0.000184	CcSEcCtD
Regadenoson—Anxiety—Prednisone—asthma	4.05e-05	0.000184	CcSEcCtD
Regadenoson—Insomnia—Dexamethasone—asthma	4.05e-05	0.000184	CcSEcCtD
Regadenoson—Insomnia—Betamethasone—asthma	4.05e-05	0.000184	CcSEcCtD
Regadenoson—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	4.04e-05	0.000183	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—BDKRB2—asthma	4.03e-05	0.000614	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—POMC—asthma	4.03e-05	0.000613	CbGpPWpGaD
Regadenoson—Gastrointestinal pain—Methylprednisolone—asthma	4.02e-05	0.000182	CcSEcCtD
Regadenoson—Paraesthesia—Betamethasone—asthma	4.02e-05	0.000182	CcSEcCtD
Regadenoson—Paraesthesia—Dexamethasone—asthma	4.02e-05	0.000182	CcSEcCtD
Regadenoson—Discomfort—Prednisone—asthma	4.02e-05	0.000182	CcSEcCtD
Regadenoson—Hypersensitivity—Prednisolone—asthma	3.95e-05	0.000179	CcSEcCtD
Regadenoson—Urticaria—Triamcinolone—asthma	3.92e-05	0.000178	CcSEcCtD
Regadenoson—Urticaria—Methylprednisolone—asthma	3.91e-05	0.000177	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—ADCY2—asthma	3.9e-05	0.000594	CbGpPWpGaD
Regadenoson—Anaphylactic shock—Prednisone—asthma	3.9e-05	0.000177	CcSEcCtD
Regadenoson—Abdominal pain—Methylprednisolone—asthma	3.89e-05	0.000176	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—IL3—asthma	3.89e-05	0.000592	CbGpPWpGaD
Regadenoson—Gastrointestinal disorder—Betamethasone—asthma	3.86e-05	0.000175	CcSEcCtD
Regadenoson—Gastrointestinal disorder—Dexamethasone—asthma	3.86e-05	0.000175	CcSEcCtD
Regadenoson—Hypersensitivity—Hydrocortisone—asthma	3.86e-05	0.000175	CcSEcCtD
Regadenoson—Shock—Prednisone—asthma	3.83e-05	0.000174	CcSEcCtD
Regadenoson—Pain—Dexamethasone—asthma	3.83e-05	0.000174	CcSEcCtD
Regadenoson—Pain—Betamethasone—asthma	3.83e-05	0.000174	CcSEcCtD
Regadenoson—Nervous system disorder—Prednisone—asthma	3.82e-05	0.000173	CcSEcCtD
Regadenoson—Tachycardia—Prednisone—asthma	3.8e-05	0.000172	CcSEcCtD
Regadenoson—Skin disorder—Prednisone—asthma	3.79e-05	0.000172	CcSEcCtD
Regadenoson—Hyperhidrosis—Prednisone—asthma	3.77e-05	0.000171	CcSEcCtD
Regadenoson—Asthenia—Hydrocortisone—asthma	3.76e-05	0.00017	CcSEcCtD
Regadenoson—Feeling abnormal—Betamethasone—asthma	3.69e-05	0.000167	CcSEcCtD
Regadenoson—Feeling abnormal—Dexamethasone—asthma	3.69e-05	0.000167	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—KNG1—asthma	3.67e-05	0.000559	CbGpPWpGaD
Regadenoson—Gastrointestinal pain—Betamethasone—asthma	3.66e-05	0.000166	CcSEcCtD
Regadenoson—Gastrointestinal pain—Dexamethasone—asthma	3.66e-05	0.000166	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—POMC—asthma	3.66e-05	0.000557	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—AGTR1—asthma	3.65e-05	0.000556	CbGpPWpGaD
Regadenoson—Hypersensitivity—Triamcinolone—asthma	3.63e-05	0.000165	CcSEcCtD
Regadenoson—Hypersensitivity—Methylprednisolone—asthma	3.63e-05	0.000164	CcSEcCtD
Regadenoson—Diarrhoea—Hydrocortisone—asthma	3.58e-05	0.000163	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—CCL2—asthma	3.58e-05	0.000545	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—IL6R—asthma	3.57e-05	0.000543	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CXCL10—asthma	3.56e-05	0.000543	CbGpPWpGaD
Regadenoson—Urticaria—Betamethasone—asthma	3.56e-05	0.000161	CcSEcCtD
Regadenoson—Urticaria—Dexamethasone—asthma	3.56e-05	0.000161	CcSEcCtD
Regadenoson—Musculoskeletal discomfort—Prednisone—asthma	3.55e-05	0.000161	CcSEcCtD
Regadenoson—ADORA2A—GPCR downstream signaling—RHOA—asthma	3.55e-05	0.000541	CbGpPWpGaD
Regadenoson—Dizziness—Prednisolone—asthma	3.55e-05	0.000161	CcSEcCtD
Regadenoson—Asthenia—Triamcinolone—asthma	3.54e-05	0.00016	CcSEcCtD
Regadenoson—Abdominal pain—Dexamethasone—asthma	3.54e-05	0.00016	CcSEcCtD
Regadenoson—Abdominal pain—Betamethasone—asthma	3.54e-05	0.00016	CcSEcCtD
Regadenoson—Asthenia—Methylprednisolone—asthma	3.53e-05	0.00016	CcSEcCtD
Regadenoson—Insomnia—Prednisone—asthma	3.53e-05	0.00016	CcSEcCtD
Regadenoson—Paraesthesia—Prednisone—asthma	3.5e-05	0.000159	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—NTRK1—asthma	3.5e-05	0.000533	CbGpPWpGaD
Regadenoson—Dizziness—Hydrocortisone—asthma	3.46e-05	0.000157	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—ADRB2—asthma	3.46e-05	0.000527	CbGpPWpGaD
Regadenoson—Rash—Prednisolone—asthma	3.38e-05	0.000153	CcSEcCtD
Regadenoson—Dermatitis—Prednisolone—asthma	3.38e-05	0.000153	CcSEcCtD
Regadenoson—Diarrhoea—Methylprednisolone—asthma	3.37e-05	0.000153	CcSEcCtD
Regadenoson—Headache—Prednisolone—asthma	3.36e-05	0.000152	CcSEcCtD
Regadenoson—Vomiting—Hydrocortisone—asthma	3.33e-05	0.000151	CcSEcCtD
Regadenoson—Rash—Hydrocortisone—asthma	3.3e-05	0.00015	CcSEcCtD
Regadenoson—Dermatitis—Hydrocortisone—asthma	3.3e-05	0.00015	CcSEcCtD
Regadenoson—Headache—Hydrocortisone—asthma	3.28e-05	0.000149	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—ITPR1—asthma	3.27e-05	0.000499	CbGpPWpGaD
Regadenoson—Dizziness—Triamcinolone—asthma	3.26e-05	0.000148	CcSEcCtD
Regadenoson—Dizziness—Methylprednisolone—asthma	3.25e-05	0.000148	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—RHOA—asthma	3.22e-05	0.000491	CbGpPWpGaD
Regadenoson—Feeling abnormal—Prednisone—asthma	3.21e-05	0.000146	CcSEcCtD
Regadenoson—Asthenia—Betamethasone—asthma	3.21e-05	0.000146	CcSEcCtD
Regadenoson—Asthenia—Dexamethasone—asthma	3.21e-05	0.000146	CcSEcCtD
Regadenoson—Gastrointestinal pain—Prednisone—asthma	3.19e-05	0.000145	CcSEcCtD
Regadenoson—Nausea—Prednisolone—asthma	3.19e-05	0.000144	CcSEcCtD
Regadenoson—Vomiting—Triamcinolone—asthma	3.14e-05	0.000142	CcSEcCtD
Regadenoson—Vomiting—Methylprednisolone—asthma	3.13e-05	0.000142	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—CD86—asthma	3.12e-05	0.000475	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—CXCL8—asthma	3.12e-05	0.000475	CbGpPWpGaD
Regadenoson—Nausea—Hydrocortisone—asthma	3.11e-05	0.000141	CcSEcCtD
Regadenoson—Rash—Triamcinolone—asthma	3.11e-05	0.000141	CcSEcCtD
Regadenoson—Dermatitis—Triamcinolone—asthma	3.11e-05	0.000141	CcSEcCtD
Regadenoson—Rash—Methylprednisolone—asthma	3.1e-05	0.000141	CcSEcCtD
Regadenoson—Dermatitis—Methylprednisolone—asthma	3.1e-05	0.000141	CcSEcCtD
Regadenoson—Urticaria—Prednisone—asthma	3.1e-05	0.00014	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—EDN1—asthma	3.09e-05	0.000471	CbGpPWpGaD
Regadenoson—Headache—Triamcinolone—asthma	3.09e-05	0.00014	CcSEcCtD
Regadenoson—Headache—Methylprednisolone—asthma	3.08e-05	0.00014	CcSEcCtD
Regadenoson—Abdominal pain—Prednisone—asthma	3.08e-05	0.00014	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—CCL5—asthma	3.07e-05	0.000467	CbGpPWpGaD
Regadenoson—Diarrhoea—Dexamethasone—asthma	3.06e-05	0.000139	CcSEcCtD
Regadenoson—Diarrhoea—Betamethasone—asthma	3.06e-05	0.000139	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—PLA2G4A—asthma	3.06e-05	0.000466	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CSF2—asthma	3.02e-05	0.00046	CbGpPWpGaD
Regadenoson—ADORA2A—GPCR downstream signaling—IL2—asthma	2.98e-05	0.000453	CbGpPWpGaD
Regadenoson—Dizziness—Betamethasone—asthma	2.96e-05	0.000134	CcSEcCtD
Regadenoson—Dizziness—Dexamethasone—asthma	2.96e-05	0.000134	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—SMAD3—asthma	2.94e-05	0.000448	CbGpPWpGaD
Regadenoson—Nausea—Triamcinolone—asthma	2.93e-05	0.000133	CcSEcCtD
Regadenoson—Nausea—Methylprednisolone—asthma	2.92e-05	0.000133	CcSEcCtD
Regadenoson—Hypersensitivity—Prednisone—asthma	2.87e-05	0.00013	CcSEcCtD
Regadenoson—Vomiting—Dexamethasone—asthma	2.85e-05	0.000129	CcSEcCtD
Regadenoson—Vomiting—Betamethasone—asthma	2.85e-05	0.000129	CcSEcCtD
Regadenoson—ADORA2A—Signaling by GPCR—CXCL8—asthma	2.83e-05	0.000431	CbGpPWpGaD
Regadenoson—Rash—Dexamethasone—asthma	2.82e-05	0.000128	CcSEcCtD
Regadenoson—Rash—Betamethasone—asthma	2.82e-05	0.000128	CcSEcCtD
Regadenoson—Dermatitis—Dexamethasone—asthma	2.82e-05	0.000128	CcSEcCtD
Regadenoson—Dermatitis—Betamethasone—asthma	2.82e-05	0.000128	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—PPP2CA—asthma	2.82e-05	0.000429	CbGpPWpGaD
Regadenoson—Headache—Betamethasone—asthma	2.8e-05	0.000127	CcSEcCtD
Regadenoson—Headache—Dexamethasone—asthma	2.8e-05	0.000127	CcSEcCtD
Regadenoson—Asthenia—Prednisone—asthma	2.8e-05	0.000127	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—CCR5—asthma	2.76e-05	0.000421	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IL2RA—asthma	2.72e-05	0.000415	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—IL2—asthma	2.7e-05	0.000412	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—C3—asthma	2.7e-05	0.000411	CbGpPWpGaD
Regadenoson—Diarrhoea—Prednisone—asthma	2.67e-05	0.000121	CcSEcCtD
Regadenoson—Nausea—Dexamethasone—asthma	2.66e-05	0.000121	CcSEcCtD
Regadenoson—Nausea—Betamethasone—asthma	2.66e-05	0.000121	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—PDGFB—asthma	2.63e-05	0.0004	CbGpPWpGaD
Regadenoson—Dizziness—Prednisone—asthma	2.58e-05	0.000117	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—LEP—asthma	2.52e-05	0.000383	CbGpPWpGaD
Regadenoson—Vomiting—Prednisone—asthma	2.48e-05	0.000112	CcSEcCtD
Regadenoson—Rash—Prednisone—asthma	2.46e-05	0.000111	CcSEcCtD
Regadenoson—Dermatitis—Prednisone—asthma	2.46e-05	0.000111	CcSEcCtD
Regadenoson—Headache—Prednisone—asthma	2.44e-05	0.000111	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—FN1—asthma	2.37e-05	0.000361	CbGpPWpGaD
Regadenoson—Nausea—Prednisone—asthma	2.32e-05	0.000105	CcSEcCtD
Regadenoson—ADORA2A—Signaling Pathways—POMC—asthma	2.16e-05	0.000329	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CCL2—asthma	2.11e-05	0.000322	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IL6R—asthma	2.11e-05	0.000321	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—EGFR—asthma	2.07e-05	0.000315	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—SERPINE1—asthma	1.97e-05	0.000301	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—RHOA—asthma	1.9e-05	0.00029	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—NOS3—asthma	1.88e-05	0.000287	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—CXCL8—asthma	1.67e-05	0.000255	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IL2—asthma	1.6e-05	0.000243	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling by GPCR—IL6—asthma	1.59e-05	0.000242	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—MMP9—asthma	1.51e-05	0.00023	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—PTEN—asthma	1.5e-05	0.000229	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—VEGFA—asthma	1.36e-05	0.000207	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—STAT3—asthma	1.34e-05	0.000205	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—TGFB1—asthma	1.25e-05	0.00019	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—EGFR—asthma	1.22e-05	0.000186	CbGpPWpGaD
Regadenoson—ADORA2A—Signaling Pathways—IL6—asthma	9.39e-06	0.000143	CbGpPWpGaD
